Structure-based drug repositioning: Potential and limits
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 68, 192-198
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Drug repositioning for orphan diseasesBriefings in Bioinformatics, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Structural space of protein–protein interfaces is degenerate, close to complete, and highly connectedProceedings of the National Academy of Sciences, 2010
- DrugBank 3.0: a comprehensive resource for 'Omics' research on drugsNucleic Acids Research, 2010
- FINDSITE: a combined evolution/structure-based approach to protein function predictionBriefings in Bioinformatics, 2009
- The SWISS-MODEL Repository and associated resourcesNucleic Acids Research, 2008
- LigASite a database of biologically relevant binding sites in proteins with known apo-structuresNucleic Acids Research, 2007
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profilingBritish Journal of Pharmacology, 2007
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- The Protein Data BankNucleic Acids Research, 2000